Ropivacaine (rINN) is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin. Ropivacaine was developed after bupivacaine was noted to be associated with cardiac arrest, particularly in pregnant women. Ropivacaine was found to have less cardiotoxicity than bupivacaine in animal models. Synonyms: (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide Hydrochloride Hydrate, LEA-103 CAS No: 132112-35-7 Molecular Formula: C17H29ClN2O2 Molecular Weight: 328.88 Appearance: White crystalline powder Purity: 98.5% Identification: 1. Positive reaction 2. IR meets requirement Water: 5-6% Heavy Metals: 0.001% Related Substances: Bupivacaine: 0.2% Single Impurities: 0.1% Total Impurities: 0.5% Solubility: Water Conforms to USP
Molecular Weight:
328.88
Purity:
98.5%
Form:
White crystalline powder
CAS Number:
[132112-35-7]
* VAT and and shipping costs not included. Errors and price changes excepted
